These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30575417)

  • 21. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
    Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
    Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage-Animal, Experimental Study.
    Baig MS; Kolasa-Wołosiuk A; Pilutin A; Safranow K; Baranowska-Bosiacka I; Kabat-Koperska J; Wiszniewska B
    Int J Environ Res Public Health; 2019 May; 16(10):. PubMed ID: 31100850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
    Imperato-McGinley J
    Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dutasteride: a potent dual inhibitor of 5-alpha-reductase for benign prostatic hyperplasia.
    Rabasseda X
    Drugs Today (Barc); 2004 Aug; 40(8):649-61. PubMed ID: 15510237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential targets in the discovery of new hair growth promoters for androgenic alopecia.
    Jain R; De-Eknamkul W
    Expert Opin Ther Targets; 2014 Jul; 18(7):787-806. PubMed ID: 24873677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
    Makridakis NM; di Salle E; Reichardt JK
    Pharmacogenetics; 2000 Jul; 10(5):407-13. PubMed ID: 10898110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
    Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
    Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
    Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta).
    Prahalada S; Tarantal AF; Harris GS; Ellsworth KP; Clarke AP; Skiles GL; MacKenzie KI; Kruk LF; Ablin DS; Cukierski MA; Peter CP; vanZwieten MJ; Hendrickx AG
    Teratology; 1997 Feb; 55(2):119-31. PubMed ID: 9143092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors.
    Karnsomwan W; Netcharoensirisuk P; Rungrotmongkol T; De-Eknamkul W; Chamni S
    Chem Pharm Bull (Tokyo); 2017; 65(3):253-260. PubMed ID: 28250347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS; Cai X; Abasolo I; Wang Z
    Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avicequinone C isolated from Avicennia marina exhibits 5α-reductase-type 1 inhibitory activity using an androgenic alopecia relevant cell-based assay system.
    Jain R; Monthakantirat O; Tengamnuay P; De-Eknamkul W
    Molecules; 2014 May; 19(5):6809-21. PubMed ID: 24858268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5 alpha-reductase in intact DU145 cells: evidence for isozyme I and evaluation of novel inhibitors.
    Reichert W; Jose J; Hartmann RW
    Arch Pharm (Weinheim); 2000 Jul; 333(7):201-4. PubMed ID: 10965593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.
    Hirosumi J; Nakayama O; Fagan T; Sawada K; Chida N; Inami M; Takahashi S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):357-63. PubMed ID: 7734404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5alpha-reductase activity in the prostate.
    Steers WD
    Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of 5α-reductase inhibitors in benign prostatic diseases.
    Azzouni F; Mohler J
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):222-30. PubMed ID: 22333687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride.
    Xiao Q; Wang L; Supekar S; Shen T; Liu H; Ye F; Huang J; Fan H; Wei Z; Zhang C
    Nat Commun; 2020 Oct; 11(1):5430. PubMed ID: 33110062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
    Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL
    J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type-1 steroid 5 alpha-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5 alpha-reductase.
    Gerst C; Dalko M; Pichaud P; Galey JB; Buan B; Bernard BA
    Exp Dermatol; 2002 Feb; 11(1):52-8. PubMed ID: 11962492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.